OverviewOzempicWegovyMounjaroGenericsCostResearchSide Effectsvs Surgery
← Back to GLP-1 Hub
Eli Lilly · Launched India August 2025 · Dual GIP+GLP-1

Mounjaro in India

Tirzepatide — the world's most powerful approved weight loss drug. Dual GIP+GLP-1 receptor agonist.

20–22%
Weight loss at max dose
2.5%
HbA1c reduction
Dual
GIP + GLP-1 mechanism
No generic
Available yet in India
Book ConsultationWhatsApp Us

What makes Mounjaro different?

💊 GLP-1 drugs (Ozempic, Wegovy)
Activate only GLP-1 receptors. Excellent for diabetes and weight loss. 10–17% body weight loss depending on dose.
🚀 Mounjaro (tirzepatide)
Activates BOTH GIP receptors AND GLP-1 receptors. GIP enhances insulin secretion and works synergistically with GLP-1 for greater metabolic effect. Result: 20–22% weight loss — approaching bariatric surgery outcomes.

SURMOUNT Trials — What the Data Shows

The SURMOUNT clinical trial programme is the most comprehensive weight loss trial ever conducted.

SURMOUNT-1
22.5% weight loss at 15mg in non-diabetic patients over 72 weeks
SURMOUNT-2
15.7% weight loss at 15mg in patients with Type 2 diabetes
SURPASS-CVOT
14% reduction in major cardiovascular events vs semaglutide
SURMOUNT-OSA
63% reduction in sleep apnea severity at 15mg

Mounjaro Dose Schedule & Cost in India (2026)

No generic tirzepatide is available in India yet. The tirzepatide patent is in force. Expect generic launch in 2029–2030.
DoseSchedule₹/Week₹/Month
2.5mgWeeks 1–4 (starter)₹3,281₹13,125
5mgWeeks 5–8₹4,102₹16,406
7.5mgWeeks 9–12₹5,156₹20,625
10mgWeeks 13–16₹5,156₹20,625
12.5mgWeeks 17–20₹6,445₹25,781
15mg ★Week 21+ (max dose)₹6,445₹25,781
★ Maximum dose shown in trials to produce 22.5% weight loss

Who should consider Mounjaro?

✓BMI ≥30 who want maximum weight loss
✓Type 2 diabetes with BMI ≥27 — best HbA1c reduction
✓Patients who failed Ozempic or Wegovy
✓Those willing to pay premium for better outcomes
✓Patients with concurrent sleep apnea (SURMOUNT-OSA)

Mounjaro cautions

⚠️Most expensive GLP-1 in India (₹13,000–26,000/month)
⚠️Newer drug — less than 4 years post-approval safety data
⚠️Higher rate of GI side effects at higher doses
⚠️No generic available — no price reduction expected until 2029
⚠️Contraindicated in MTC history and MEN2 syndrome

Is Mounjaro worth the cost for you?

Our endocrinology team assesses whether Mounjaro's additional weight loss justifies the premium over Ozempic or generics for your specific case.

Book Free ConsultationMounjaro vs Bariatric Surgery →
📞 CallWhatsAppFree Consult